Workflow
超高效液相色谱串联质谱系统
icon
Search documents
科华生物股价下跌2.49% 公司聘任新财务总监
Jin Rong Jie· 2025-07-31 19:14
Core Viewpoint - KHBio's stock price closed at 6.66 yuan on July 31, reflecting a decrease of 0.17 yuan or 2.49% from the previous trading day [1] Group 1: Company Overview - KHBio operates in the medical device industry, focusing on the research, production, and sales of in vitro diagnostic reagents and medical instruments [1] - The company's product range includes clinical testing, immunodiagnostics, and molecular diagnostics [1] Group 2: Recent Developments - On July 31, KHBio's board approved the appointment of Zang Xianfeng as the new Chief Financial Officer [1] - The company announced that its ultra-high-performance liquid chromatography-tandem mass spectrometry system is an open system, which, when used with the company's mass spectrometry reagents, enhances the stability and accuracy of test results [1] - KHBio revealed a collaboration with Waters Corporation to launch two products that have received national medical device registration certificates, utilizing a "dual-brand" model to create an integrated platform [1] Group 3: Market Activity - On July 31, KHBio experienced a net outflow of main funds amounting to 17.06 million yuan, representing 0.5% of its circulating market value [1]
科华生物:公司超高效液相色谱串联质谱系统是开放系统
Zheng Quan Ri Bao Wang· 2025-07-31 12:01
证券日报网讯科华生物(002022)7月31日在互动平台回答投资者提问时表示,公司超高效液相色谱串 联质谱系统是开放系统,但与公司质谱试剂配套使用,可以提高检测结果的稳定性和准确性。此外,公 司以超高效液相色谱串联质谱为核心技术,构建了"前处理自动化+质谱检测系统+试剂配套"的一体化 平台,覆盖营养代谢、药物浓度监测、内分泌激素检测、生物标志物分析和临床毒理研究等五大核心领 域,可为客户提供整体解决方案,能提高检测效率及检测结果的稳定性,赋能精准医疗。 ...